Search results
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer
TipRanks via Yahoo Finance· 19 hours agoRisk and reward are the yin and yang of stock trading, the two essential yet opposing forces in...
ARAMARK shares target raised by Oppenheimer on strong Q2 performance By Investing.com
Investing.com· 3 hours agoOn Wednesday, Oppenheimer adjusted its outlook on ARAMARK Holdings (NYSE:ARMK) shares, increasing...
Oppenheimer raises IAC shares target by $10 By Investing.com
Investing.com· 24 hours agoOn Thursday, Oppenheimer adjusted its outlook on IAC/InterActiveCorp (NASDAQ:IAC), increasing the...
Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target Increased to $60.00 by Analysts at Oppenheimer
ETF DAILY NEWS· 5 hours agoCorbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report) had its target price upped by equities research analysts at Oppenheimer from $58.00 to $60.00 in a research report issued ...
Oppenheimer Expands Its Investment Banking Capabilities with the Hires of Dmitry Gladkov and...
FOX40 Sacramento· 2 days agoNEW YORK, May 8, 2024 /PRNewswire/ -- Oppenheimer Europe (Oppenheimer) — a subsidiary of Oppenheimer...
Investors Brace For What's Next Following A Rough April
Investor's Business Daily· 1 hour ago"I'm sticking with my year-end price target of 5500 for the S&P 500," said John Stoltzfus, chief...
Q1 2024 Ormat Technologies Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 hours agoFinancial Officer; Ormat Technologies Inc Josh Carroll; Investor Relations; Alpha IR Group Andre Adams; Analyst; Oppenheimer & Co., Inc. Justin Clare; Analyst; Roth MKM Ryan ...
Viridian Therapeutics shares target cut by Oppenheimer By Investing.com
Investing.com· 24 hours agoOn Thursday, Oppenheimer adjusted its price target for Viridian Therapeutics (NASDAQ:VRDN), a...
Stock prices are now at 'more attractive levels' - Oppenheimer
Investing.com· 4 days agoStock prices are now at 'more attractive levels' - Oppenheimer
Maplebear (NASDAQ:CART) Earns Hold Rating from Benchmark
ETF DAILY NEWS· 5 hours agoWolfe Research upped their price target on shares of Maplebear from $35.00 to $39.00 and gave the company an outperform rating in a research note on Tuesday, March 5th. Oppenheimer& ...
